Acute disseminated encephalomyelitis
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Acute disseminated encephalomyelitis (ADEM) is an immune-mediated inflammatory disorder of the CNS characterized by a widespread demyelination that predominantly involves the white matter of the brain and spinal cord. The condition is usually precipitated by a viral infection or vaccination. The presenting features include an acute encephalopathy with multifocal neurologic signs and deficits. Children are preferentially affected. In the absence of specific biologic markers, the diagnosis of ADEM is still based on the clinical and radiologic features. Although ADEM usually has a monophasic course, recurrent or multiphasic forms have been reported, raising diagnostic difficulties in distinguishing these cases from multiple sclerosis (MS). The International Pediatric MS Study Group proposes uniform definitions for ADEM and its variants. We discuss some of the difficulties in the interpretation of available literature due to the different terms and definitions used. In addition, this review summarizes current knowledge of the main aspects of ADEM, including its clinical and radiologic diagnostic features, epidemiology, pathogenesis, and outcome. An overview of ADEM treatment in children is provided. Finally, the controversies surrounding pediatric MS and ADEM are addressed.
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
- Article
- Abstract
- Epidemiology.
- Clinical presentation.
- MRI features.
- Advanced neuroimaging techniques.
- Monophasic and multiphasic ADEM.
- Acute hemorrhagic leukoencephalitis.
- Controversies in diagnosis based on published studies: Rationale for proposed definitions.
- ADEM definitions.
- Differential diagnosis.
- Treatment and management.
- Steroids.
- Immunoglobulin.
- Plasma exchange.
- Other therapies.
- Outcome and prognosis.
- Treated ADEM.
- Neurocognitive outcome.
- ADEM and MS.
- Pathogenesis.
- Research/future directions.
- Appendix
- Footnotes
- References
- Figures & Data
- Info & Disclosures
Dr. Emily Gilmore and Dr. Rachel Beekman
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Consensus definitions proposed for pediatric multiple sclerosis and related disordersLauren B. Krupp, Brenda Banwell, Silvia Tenembaum et al.Neurology, April 16, 2007 -
Articles
Challenges in the classification of pediatric multiple sclerosis and future directionsAnita L. Belman, Tanuja Chitnis, Christel Renoux et al.Neurology, April 16, 2007 -
Article
Acute disseminated encephalomyelitis in 228 patientsA retrospective, multicenter US studyDiederik L.H. Koelman, Salim Chahin, Soe S. Mar et al.Neurology, May 04, 2016 -
Article
Acute Disseminated Encephalomyelitis and Acute Hemorrhagic Leukoencephalitis Following COVID-19Systematic Review and Meta-synthesisGiovanna S. Manzano, Caleb R. S. McEntire, Maria Martinez-Lage et al.Neurology: Neuroimmunology & Neuroinflammation, August 27, 2021